Global Endoscopic Hemostasis Devices (General Surgery) Market, By Mechanical Devices (Clips, Ligation Devices, Suturing Devices and Stents) Injection Devices (Injection and Needles), Thermal Devices (Hemostatic Probes, Hemostatic Forceps, Heater Probe, Argon Plasma Coagulation, Radiofrequency Ablation and Cryotherapy), Topical Devices (Hemostatic Spray and Others), End User Industry (Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Others) – Industry Trends and Forecast to 2031
Endoscopic Hemostasis Devices (General Surgery) Market Analysis
Endoscopic hemostasis devices (general surgery) market is advancing with innovative technologies such as hemostatic powders, clips, and thermal devices. Latest methods emphasize minimally invasive procedures, enhancing patient recovery and outcomes. Growth is driven by rising gastrointestinal disorders and aging populations. Insights reveal a focus on improving device efficacy and expanding applications in diverse surgical settings.
Endoscopic Hemostasis Devices (General Surgery) Market Size
The global endoscopic hemostasis devices (general surgery) market size was valued at USD 1.50 billion in 2023 and is projected to reach USD 2.43 billion by 2031, with a CAGR of 6.21% during the forecast period 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Mechanical Devices (Clips, Ligation Devices, Suturing Devices and Stents) Injection Devices (Injection and Needles), Thermal Devices (Hemostatic Probes, Hemostatic Forceps, Heater Probe, Argon Plasma Coagulation, Radiofrequency Ablation and Cryotherapy), Topical Devices (Hemostatic Spray and Others), End User Industry (Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.), Cook (U.S.), Diversatek, Inc. (U.S.), Olympus America (Japan), STERIS (U.S.), MICRO-TECH (Nanjing) Co., Ltd. (China), Integra LifeSciences Corporation (U.S.), Sklar Surgical Instruments (U.S.), Merit Medical Systems (U.S.), Abbott (U.S.), Siemens (Germany), HORIBA, Ltd. (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Nova Biomedical (U.S.), Sysmex (Japan), and BD (U.S.)
|
|
Market Opportunities
|
|
Endoscopic Hemostasis Devices (General Surgery) Market Definition
Endoscopic hemostasis devices are tools used in general surgery to control bleeding within the gastrointestinal tract. These devices include clips, thermal probes, and injection needles. They enable minimally invasive procedures to seal blood vessels, promoting faster recovery and reducing the need for open surgery.
Endoscopic Hemostasis Devices (General Surgery) Market Dynamics
Drivers
- Increasing Prevalence of Gastrointestinal Disorders
The rising prevalence of gastrointestinal disorders such as peptic ulcers, gastric varices, and gastrointestinal cancers is driving the demand for endoscopic hemostasis devices. For instance, a surge in peptic ulcer cases requires effective bleeding control during endoscopy, thereby boosting the market. As these conditions become more common, the need for advanced hemostasis tools in general surgery continues to grow, propelling market expansion.
- Increasing Minimally Invasive Surgery Preference
Patients and healthcare providers increasingly prefer minimally invasive surgeries because these procedures offer faster recovery times, reduced complications, and lower costs. For example, a patient undergoing endoscopic treatment for a bleeding peptic ulcer can expect a shorter hospital stay and quicker return to normal activities compared to traditional surgery. This growing preference significantly drives the demand for endoscopic hemostasis devices, fueling market growth.
Opportunities
- Rising Number of Endoscopic Procedures
The rising number of endoscopic hemostasis procedure for diagnostic and therapeutic purposes in general surgery significantly boosts the demand for hemostasis devices. For instance, the increasing use of endoscopy to treat peptic ulcers and gastrointestinal bleeding creates substantial market opportunities. As hospitals and clinics adopt more endoscopic techniques, the need for effective hemostasis tools grows, driving innovation and expanding the market for these essential medical devices.
- Rise in Gastrointestinal Cancer Cases
The rise in gastrointestinal cancer cases, such as colorectal and stomach cancers, necessitates the frequent use of endoscopic hemostasis devices to manage bleeding during diagnostic and therapeutic procedures. For instance, patients undergoing endoscopic resection of tumors often require hemostatic agents or clips to control bleeding. This increasing need creates significant market opportunities for manufacturers of advanced hemostasis devices, fostering growth and innovation in the industry.
Restraints/Challenges
- Risk of Complications
The risk of complications, including infection, bleeding, and other adverse outcomes, poses a significant deterrent to both patients and healthcare providers considering endoscopic procedures. Despite their minimally invasive nature, these risks can lead to hesitancy in adopting such procedures, impacting market growth. Concerns about safety and potential complications may discourage widespread acceptance and utilization of endoscopic hemostasis devices in general surgery.
- Disruptions of Supply Chain
Disruptions in the global supply chain, caused by geopolitical tensions, pandemics, and natural disasters, significantly impact the availability of endoscopic hemostasis devices. These disruptions can lead to shortages, hindering market stability and exacerbating challenges in meeting demand. Manufacturers and healthcare providers face uncertainty in sourcing essential components and delivering timely supplies to healthcare facilities, potentially limiting patient access to necessary medical treatments.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Endoscopic Hemostasis Devices (General Surgery) Market Scope
The market is segmented on the basis of mechanical devices, injection devices, thermal devices, topical devices and end user industry. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Mechanical Devices
- Clips
- Ligation Devices
- Suturing Devices
- Stents
Injection Devices
- Injection
- Needles
Thermal Devices
- Hemostatic Probes
- Hemostatic Forceps
- Heater Probe
- Argon Plasma Coagulation
- Radiofrequency Ablation
- Cryotherapy
Topical Devices
- Hemostatic Spray
- Others
End User Industry
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
Endoscopic Hemostasis Devices (General Surgery) Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, mechanical devices, injection devices, thermal devices, topical devices and end user industry as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the endoscopic hemostasis devices (general surgery) market, driven by the region's sophisticated healthcare facilities. This leadership is bolstered by advanced medical technologies and a robust healthcare infrastructure, ensuring high adoption rates and continual advancements in surgical techniques.
Asia-Pacific is expected to grow at a rapid and profitable rate in the endoscopic hemostasis devices (general surgery) market due to increased healthcare infrastructure spending, a growing geriatric population, and rising personal disposable income.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Endoscopic Hemostasis Devices (General Surgery) Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- Boston Scientific Corporation (U.S.)
- CONMED Corporation (U.S.)
- Cook (U.S.)
- Diversatek, Inc. (U.S.)
- Olympus America (Japan)
- STERIS (U.S.)
- MICRO-TECH (Nanjing) Co., Ltd. (China)
- Integra LifeSciences Corporation (U.S.)
- Sklar Surgical Instruments (U.S.)
- Merit Medical Systems (U.S.)
- Abbott (U.S.)
- Siemens (Germany)
- HORIBA, Ltd. (Japan)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- Nova Biomedical (U.S.)
- Sysmex (Japan)
- BD (U.S.)
SKU-